Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 400 shares, a decrease of 73.3% from the March 15th total of 1,500 shares. Based on an average trading volume of 16,400 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are sold short.
Arkema Price Performance
ARKAY stock traded up $0.17 during trading on Friday, hitting $69.81. The company had a trading volume of 14,031 shares, compared to its average volume of 16,587. The business has a 50 day moving average of $80.46 and a 200 day moving average of $81.25. The firm has a market capitalization of $5.31 billion, a price-to-earnings ratio of 13.96, a P/E/G ratio of 0.53 and a beta of 1.18. The company has a current ratio of 2.11, a quick ratio of 1.54 and a debt-to-equity ratio of 0.48. Arkema has a fifty-two week low of $64.94 and a fifty-two week high of $111.13.
About Arkema
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Articles
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.